Kawanishi H
J Clin Med. 2024; 13(3).
PMID: 38337341
PMC: 10856111.
DOI: 10.3390/jcm13030647.
Kolbrink B, Schussel K, von Samson-Himmelstjerna F, Esser G, Floege J, Kunzendorf U
Nephrol Dial Transplant. 2023; 38(11):2528-2536.
PMID: 37202223
PMC: 10615626.
DOI: 10.1093/ndt/gfad099.
Nardelli L, Scalamogna A, Messa P, Gallieni M, Cacciola R, Tripodi F
Medicina (Kaunas). 2022; 58(2).
PMID: 35208541
PMC: 8875254.
DOI: 10.3390/medicina58020214.
Nechifor A, Goran A, Grosu V, Bungau C, Albu P, Grosu A
Membranes (Basel). 2021; 11(6).
PMID: 34203680
PMC: 8232166.
DOI: 10.3390/membranes11060445.
de Carvalho Ribeiro P, Oliveira L, Abbud Filho M, Caldas H
Stem Cells Int. 2020; 2020:8894590.
PMID: 32831854
PMC: 7428838.
DOI: 10.1155/2020/8894590.
Stem Cell Therapies in Kidney Diseases: Progress and Challenges.
Rota C, Morigi M, Imberti B
Int J Mol Sci. 2019; 20(11).
PMID: 31181604
PMC: 6600599.
DOI: 10.3390/ijms20112790.
Optimizing haemodialysate composition.
Locatelli F, La Milia V, Violo L, Del Vecchio L, di Filippo S
Clin Kidney J. 2015; 8(5):580-9.
PMID: 26413285
PMC: 4581377.
DOI: 10.1093/ckj/sfv057.
Functional genomic analysis identifies indoxyl sulfate as a major, poorly dialyzable uremic toxin in end-stage renal disease.
Jhawar S, Singh P, Torres D, Ramirez-Valle F, Kassem H, Banerjee T
PLoS One. 2015; 10(3):e0118703.
PMID: 25811877
PMC: 4374671.
DOI: 10.1371/journal.pone.0118703.
Prognostic utility of plasma S100A12 levels to establish a novel scoring system for predicting mortality in maintenance hemodialysis patients: a two-year prospective observational study in Japan.
Shiotsu Y, Mori Y, Nishimura M, Hatta T, Imada N, Maki N
BMC Nephrol. 2013; 14:16.
PMID: 23324110
PMC: 3552940.
DOI: 10.1186/1471-2369-14-16.
Multipass haemodialysis: a novel dialysis modality.
Heaf J, Axelsen M, Pedersen R
Nephrol Dial Transplant. 2012; 28(5):1255-64.
PMID: 23136214
PMC: 3661003.
DOI: 10.1093/ndt/gfs484.
Renal replacement therapy review: past, present and future.
Fleming G
Organogenesis. 2011; 7(1):2-12.
PMID: 21289478
PMC: 3082028.
DOI: 10.4161/org.7.1.13997.
RENAL HOMOTRANSPLANTATION IN 24 PATIENTS.
Dunea G, Nakamoto S, Straffon R, Figueroa J, VERSACI A, SHIBAGAKI M
Br Med J. 1965; 1(5426):7-13.
PMID: 14213121
PMC: 2167879.
DOI: 10.1136/bmj.1.5426.7.
RENAL HOMOTRANSPLANTATION IN MAN IN MODIFIED RECIPIENTS.
HUME D, MAGEE J, KAUFFMAN Jr H, RITTENBURY M, Prout Jr G
Ann Surg. 1963; 158:608-44.
PMID: 14067508
PMC: 1408453.
DOI: 10.1097/00000658-196310000-00010.
Continuous venovenous hemodiafiltration for renal failure and sepsis.
Kutsogiannis D
CMAJ. 2000; 162(4):537-8.
PMID: 10701393
PMC: 1231177.
A review of continuous renal replacement therapy.
Flynn C
Ir J Med Sci. 1994; 163(7):331-40.
PMID: 8002258
DOI: 10.1007/BF02943078.
The management of acute reversible intrinsic renal failure.
Blagg C
Postgrad Med J. 1967; 43(498):290-306.
PMID: 6042389
PMC: 2466317.
DOI: 10.1136/pgmj.43.498.290.
The Jeremiah Metzger lecture: what can we do for the patient with renal failure?.
MERRILL J
Trans Am Clin Climatol Assoc. 1967; 78:173-83.
PMID: 6028234
PMC: 2441140.
[Therapy and prognosis of acute kidney insufficiency following multiple injuries].
Braun L, Albers A
Langenbecks Arch Chir. 1968; 322:1116-9.
PMID: 5758697
DOI: 10.1007/BF02454010.
[Shuntless hemodialysis by puncturing the subcutaneously fixed superficial femoral artery].
Brittinger W, von Henning G, Huber W, Strauch M, Schwarzbeck A
Klin Wochenschr. 1969; 47(7):393-4.
PMID: 5383399
DOI: 10.1007/BF01734770.
[Shuntless hemodialysis by means of puncture of the subcutaneously fixed superficial femoral artery. First dialysis experiences].
Brittinger W, Strauch M, Huber W, von Henning G, Twittenhoff W, Schwarzbeck A
Klin Wochenschr. 1969; 47(15):824-6.
PMID: 5375662
DOI: 10.1007/BF01882310.
